Cristina C Clement MS PhD
@ccclement21.bsky.social
Biochemistry, Ph.D., CUNY, NYC-2006; MS Molecular/Cell Biology, UMKC, KC,1998; Research Assist Prof: Albert Einstein CM 2007-May 2019; Associate Professor of Radiation Biology Research in Radiation Oncology: WCM (2019-present); https://www.linkedin.com/in/
Highlighted at the left: My first students from the Biochemistry Lab developed with Dr Maria Tomasz at Hunter College (200-2001).
March 23, 2025 at 5:59 AM
Highlighted at the left: My first students from the Biochemistry Lab developed with Dr Maria Tomasz at Hunter College (200-2001).
Other papers related to my SBDD designed peptidic inhibitors of thrombin:
pubmed.ncbi.nlm.nih.gov/21206024/
link.springer.com/chapter/10.1...
link.springer.com/chapter/10.1...
www.5z.com/24APS/24APS....
pubmed.ncbi.nlm.nih.gov/21206024/
link.springer.com/chapter/10.1...
link.springer.com/chapter/10.1...
www.5z.com/24APS/24APS....
Crystallization and preliminary crystallographic characterization of three peptidic inhibitors in complex with α-thrombin - PubMed
The serine protease thrombin plays a major role in thrombosis and haemostasis. This has driven interest in thrombin inhibitors as potential antithrombotic drugs. Here, the crystallization and prelimin...
pubmed.ncbi.nlm.nih.gov
March 23, 2025 at 5:54 AM
Other papers related to my SBDD designed peptidic inhibitors of thrombin:
pubmed.ncbi.nlm.nih.gov/21206024/
link.springer.com/chapter/10.1...
link.springer.com/chapter/10.1...
www.5z.com/24APS/24APS....
pubmed.ncbi.nlm.nih.gov/21206024/
link.springer.com/chapter/10.1...
link.springer.com/chapter/10.1...
www.5z.com/24APS/24APS....
papers published before being awarded PhD: shared 1st author and co-author:
pubmed.ncbi.nlm.nih.gov/15720125/
pubmed.ncbi.nlm.nih.gov/11523988/
papers published after PhD on DTI X-Ray structure and biochemical evaluation of their anticoagulant activities:
pubmed.ncbi.nlm.nih.gov/22457833/
pubmed.ncbi.nlm.nih.gov/15720125/
pubmed.ncbi.nlm.nih.gov/11523988/
papers published after PhD on DTI X-Ray structure and biochemical evaluation of their anticoagulant activities:
pubmed.ncbi.nlm.nih.gov/22457833/
DNA adduct of the mitomycin C metabolite 2,7-diaminomitosene is a nontoxic and nonmutagenic DNA lesion in vitro and in vivo - PubMed
Mitomycin C (MC) is a cytotoxic and mutagenic antitumor agent that alkylates and cross-links DNA. These effects are dependent on reductive bioactivation of MC. 2,7-Diaminomitosene (2,7-DAM) is the maj...
pubmed.ncbi.nlm.nih.gov
March 23, 2025 at 4:02 AM
papers published before being awarded PhD: shared 1st author and co-author:
pubmed.ncbi.nlm.nih.gov/15720125/
pubmed.ncbi.nlm.nih.gov/11523988/
papers published after PhD on DTI X-Ray structure and biochemical evaluation of their anticoagulant activities:
pubmed.ncbi.nlm.nih.gov/22457833/
pubmed.ncbi.nlm.nih.gov/15720125/
pubmed.ncbi.nlm.nih.gov/11523988/
papers published after PhD on DTI X-Ray structure and biochemical evaluation of their anticoagulant activities:
pubmed.ncbi.nlm.nih.gov/22457833/
Me and the award for qualifying to the top 10 speakers at the Young Investigator Award at American Peptide Society (2009).
March 23, 2025 at 3:15 AM
Me and the award for qualifying to the top 10 speakers at the Young Investigator Award at American Peptide Society (2009).
My seminar at the Pathology retreat at Albert Einstein College in 2009. A photograph from the lab of Dr Laura Santambrogio at Albert Einstein College (around 2015).
March 23, 2025 at 3:14 AM
My seminar at the Pathology retreat at Albert Einstein College in 2009. A photograph from the lab of Dr Laura Santambrogio at Albert Einstein College (around 2015).
Sloan Kettering Institute (SKI): 2005-2007: developing cell-based assay for studying drugs effects upon the proliferation of different cancer lines (breast and small lung carcinoma.
March 23, 2025 at 2:18 AM
Sloan Kettering Institute (SKI): 2005-2007: developing cell-based assay for studying drugs effects upon the proliferation of different cancer lines (breast and small lung carcinoma.
Dr. Maria Tomasz lab: Hunter College, Manhattan, 1999-2006: analysis of DNA adducts derivatized with anticancer drugs and DNA translesion synthesis using high resolution DNA sequencing gels. Columbia U., NYC-Spring 2005: Prof Wayne Hendrickson class in X-Ray.
March 23, 2025 at 2:17 AM
Dr. Maria Tomasz lab: Hunter College, Manhattan, 1999-2006: analysis of DNA adducts derivatized with anticancer drugs and DNA translesion synthesis using high resolution DNA sequencing gels. Columbia U., NYC-Spring 2005: Prof Wayne Hendrickson class in X-Ray.
Gordon Conference on "DNA and Mutagenesis"-Ventura, California 2005: poster presentation on DNA translesion synthesis.
Dr. Maria Tomasz lab: Hunter College, Lexington Avenue, Manhattan, 1999-2006: HPLC (high pressure liquid chromatography) analysis of DNA adducts derivatized with anticancer drugs.
Dr. Maria Tomasz lab: Hunter College, Lexington Avenue, Manhattan, 1999-2006: HPLC (high pressure liquid chromatography) analysis of DNA adducts derivatized with anticancer drugs.
March 23, 2025 at 1:28 AM
Gordon Conference on "DNA and Mutagenesis"-Ventura, California 2005: poster presentation on DNA translesion synthesis.
Dr. Maria Tomasz lab: Hunter College, Lexington Avenue, Manhattan, 1999-2006: HPLC (high pressure liquid chromatography) analysis of DNA adducts derivatized with anticancer drugs.
Dr. Maria Tomasz lab: Hunter College, Lexington Avenue, Manhattan, 1999-2006: HPLC (high pressure liquid chromatography) analysis of DNA adducts derivatized with anticancer drugs.